Starting from 2006 to 2010, besides carcinogenesis, other diseases feature prominently in Nrf2-related studies, notably Parkinson’s disease, Alzheimer’s disease and chronic obstructive pulmonary disease (Figure 3 and Table S2). Here, NFE2L2 is linked to Alzheimer disease.